Scientific marketing delivered at the speed your pipeline needs.
I'm a Chartered Marketer with 10+ years in life sciences. I use a purpose-built platform to produce medical, commercial and BD work for pharma, biotech, CROs and CDMOs — faster and more specifically than a traditional agency process allows.
What the work looks like.
The platform accelerates my thinking — it doesn't replace it. I use these tools to research faster, structure more rigorously and produce better work than a traditional agency process allows. Every output is reviewed, refined and signed off by me as a Chartered Marketer before it reaches you.
12 deliverables built for life sciences.
From scientific platform to HCP engagement — every output calibrated to pharma, biotech, CRO and CDMO buying cycles and reviewed before it reaches you.
Scientific Platform Builder
I build your foundational scientific narrative from scratch — evidence hierarchy, key message architecture, audience-adapted messaging for each stakeholder tier. The work a specialist medical comms agency would charge a significant premium for, produced at AI-accelerated speed with Chartered Marketer oversight.
Clinical Evidence Translator
I turn your trial data into HCP-facing materials: key message hierarchy, one-pager copy, detail aid narrative, objection handlers. Produced for review and MLR submission — not as a replacement for your regulatory sign-off process.
Market Access Strategy
I produce your payer value proposition, HEOR messaging framework, and patient access narrative — the strategic foundations your market access team builds submissions from.
Trigger Research
I run AI-assisted research targeting publicly available clinical and regulatory signals — trial registrations, IND filings, funding announcements — to identify buying windows for your CRO/CDMO services. The output is a structured BD intelligence brief: which accounts to prioritise, why now, and what to lead with.
CRO / CDMO Profiler
I produce structured intelligence on any CRO or CDMO from publicly available sources: capabilities, published case studies, therapeutic focus, recent hiring signals and BD talking points — so your team enters every conversation properly briefed.
KOL Engagement Letters
I write professional KOL outreach and collaboration letters for advisory board recruitment and endorsements.
MSL Talking Points
I produce therapy area-specific field discussion guides for Medical Science Liaisons — structured around your published evidence base, for review before field deployment.
Payer Value Brief
I build your health economics and outcomes value narrative — the commercial foundation your market access team takes into formulary conversations.
Congress Abstract
I draft congress abstracts for scientific meetings — structured for MLR submission, with clear evidence hierarchy and compliant language. Your regulatory team reviews and approves before submission.
HCP Segmentation
I build HCP segmentation frameworks — defining audience tiers by therapeutic alignment, prescribing profile and engagement criteria — so your field team has a clear, commercial targeting logic to work from.
Regulatory Copy Check
I review your promotional content against standard pharma advertising guidelines and flag potential compliance issues before your regulatory team's MLR review — reducing internal cycles and rework.
Battlecards
I produce clinical win-in-the-call tools that help your team handle competitor comparisons confidently.
12 deliverables. Every one built around your specific market —
not a template.
A Scientific Platform Builder or a set of Battlecards produced from a general brief about your therapy area will sound like every other platform or competitive tool in the sector. The science will be correct. The positioning won't be yours.
Before any work starts, I run a structured intake session — The Voice Brief. It captures how your BD or commercial team actually thinks about your market: the language your best partners use when they first get in touch, the beliefs your scientific leadership holds about your therapy area, the phrases that would never appear in a serious conversation with a CMC head or a procurement committee.
Every one of the 12 deliverables is built against that brief. The Scientific Platform reflects your evidence hierarchy, not a template one. The Trigger Research is calibrated to the buying signals your buyers actually act on. The Battlecards handle the objections your team actually faces in the room.
The platform accelerates production. The Voice Brief is what makes the output yours.
Same deliverable. Generic output vs The Voice Brief.
Our integrated sterile injectable manufacturing platform delivers end-to-end CDMO services — from formulation development through commercial supply — with a commitment to quality, compliance and on-time delivery.
We partner with innovative biotech and pharma companies to accelerate their programmes to market, leveraging our expertise in complex formulations, regulatory affairs and supply chain management.
Our state-of-the-art facilities and experienced team ensure the highest standards of GMP compliance across every stage of the manufacturing lifecycle.
- ✕Applies to every CDMO without changing a word
- ✕"Commitment to quality" — every CDMO says this
- ✕No programme-stage specificity — same for pre-IND as commercial
- ✕BD team can't use this — nothing a CMC head doesn't already assume
Tech transfers fail in the same three places almost every time. Receiving site documentation. Analytical method gaps. And the assumption that the donor site's tribal knowledge will travel.
The programmes we take on at IND-enabling stage — where the sponsor is managing CMC complexity for the first time and the timeline pressure is real — are the ones where those three failure points matter most. Our BD team spends the first conversation mapping which of the three is already a risk. That conversation is different from every other CDMO pitch the CMC lead has taken.
That's the positioning the scientific platform is built around. Not capability breadth. The specific failure mode we're structured to prevent.
- →Opens with a point of view the buyer hasn't heard before
- →Programme-stage specific — IND-enabling named precisely
- →Positions BD as diagnostic, not a pitch
- →BD team can use this — it names what they already do, in language buyers respond to
From first conversation to finished output.
Free demand generation audit
Answer 8 questions about your current programme. You get a scored diagnostic report across six life sciences-specific areas — specific findings, priority fixes, quick wins. Free, instant, no commitment.
Discovery call with Rashid directly
Not a junior. Not a chatbot. A Chartered Marketer who reads your audit before you speak and arrives with a clear opinion about what to build first, calibrated to your therapy area and buyers.
Outputs built and validated for you
I use my platform to produce the work at speed — scientific platforms, HCP materials, BD intelligence, nurture sequences — and review every output before it reaches you.
Ready to build your scientific foundation?
Start with a free life sciences marketing audit — or talk to me directly about your therapy area and what your pipeline needs first.